Lipologics is the liposomal delivery brand of Hoynoza Technologies Pvt Ltd — built around HNOVA™, Hoynoza's proprietary nano-liposomal platform.
Hoynoza Technologies Pvt Ltd is a Bengaluru biotechnology company working across regenerative medicine, advanced drug delivery and natural wellness — Innovate. Deliver. Empower. Lipologics is its liposomal delivery brand, built entirely on HNOVA™: one platform engineered once, applied across 39+ actives.
Working from Hoynoza's KIADB campus in Jigani, Bengaluru, the HNOVA™ team spans liposome formulation science, analytical characterisation and GMP process engineering — the same infrastructure behind Hoynoza's broader stem-cell, exosome and diagnostics work.
The goal is simple: give pharmaceutical, nutraceutical and cosmeceutical partners a liposomal platform they don't have to build in-house.
Lipologics concentrates one proprietary platform across a broad, documented portfolio.
One platform, limitless potential — advancing health, enhancing lives, together.
Every product is developed with complete research, data and performance validation.
Continuous investment in R&D keeps the platform ahead — today's solutions built on tomorrow's science.
Manufactured under stringent quality standards for global regulatory and commercialisation readiness.
We co-create with partners to solve complex formulation challenges and drive real outcomes.
Committed to sustainable practices that empower a healthier planet and a better future.
Lipologics is the liposomal arm of a wider biotechnology company.
The HNOVA™ platform behind Lipologics — plant-based liposomal encapsulation across 39+ actives.
Extracellular-vesicle ingredients for cosmetic and regenerative applications.
Regenerative-medicine programmes drawing on the same Bengaluru scientific bench.
Biologics development capability alongside the formulation platforms.
Formulation science, analytical characterisation and manufacturing sit together on the KIADB campus in Jigani, Bengaluru — the same infrastructure that supports Hoynoza's broader programmes.
Four directors, one campus — leading technology, projects, quality and operations for Lipologics and the HNOVA™ platform.
Guides every programme from first brief to delivery, keeping partners, timelines and documentation in step.
Leads the science behind HNOVA™ — liposome formulation, characterisation and technology development.
Owns the quality framework: batch characterisation, Certificates of Analysis and documentation-first release.
Runs projects and operations on the Bengaluru campus, from scale-up to dependable supply.